These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 28282061

  • 1. Hydroxychloroquine retinopathy.
    Yusuf IH, Sharma S, Luqmani R, Downes SM.
    Eye (Lond); 2017 Jun; 31(6):828-845. PubMed ID: 28282061
    [Abstract] [Full Text] [Related]

  • 2. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF, American Academy of Ophthalmology.
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [Abstract] [Full Text] [Related]

  • 3. [Variability of chloroquine and hydroxychloroquine retinopathy among various ethnicities].
    Giocanti-Aurégan A, Couturier A, Girmens JF, Le Mer Y, Massamba N, Barreau E, Audo I, DHU Vision Handicaps task force rétine.
    J Fr Ophtalmol; 2018 Apr; 41(4):363-367. PubMed ID: 29678344
    [Abstract] [Full Text] [Related]

  • 4. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, Mavrikakis M.
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [Abstract] [Full Text] [Related]

  • 5. Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus.
    Lee JE, Nam DR, Sung YK, Kim YJ, Jung SY.
    Sci Rep; 2023 May 04; 13(1):7270. PubMed ID: 37142639
    [Abstract] [Full Text] [Related]

  • 6. Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.
    Browning DJ, Yokogawa N, Greenberg PB, Perlman E.
    Am J Ophthalmol; 2020 Nov 04; 219():101-106. PubMed ID: 32610049
    [Abstract] [Full Text] [Related]

  • 7. Hydroxychloroquine-related retinal toxicity.
    Ding HJ, Denniston AK, Rao VK, Gordon C.
    Rheumatology (Oxford); 2016 Jun 04; 55(6):957-67. PubMed ID: 26428520
    [Abstract] [Full Text] [Related]

  • 8. Hydroxychloroquine retinopathy: an emerging problem.
    Latasiewicz M, Gourier H, Yusuf IH, Luqmani R, Sharma SM, Downes SM.
    Eye (Lond); 2017 Jun 04; 31(6):972-976. PubMed ID: 28186509
    [Abstract] [Full Text] [Related]

  • 9. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
    Melles RB, Marmor MF.
    JAMA Ophthalmol; 2014 Dec 04; 132(12):1453-60. PubMed ID: 25275721
    [Abstract] [Full Text] [Related]

  • 10. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S, Kellner U.
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar 04; 250(3):319-25. PubMed ID: 22215255
    [Abstract] [Full Text] [Related]

  • 11. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
    Ugwuegbu O, Uchida A, Singh RP, Beven L, Hu M, Kaiser S, Srivastava SK, Ehlers JP.
    Br J Ophthalmol; 2019 Jan 04; 103(1):3-7. PubMed ID: 30190364
    [Abstract] [Full Text] [Related]

  • 12. Pericentral hydroxychloroquine retinopathy in Korean patients.
    Lee DH, Melles RB, Joe SG, Lee JY, Kim JG, Lee CK, Yoo B, Koo BS, Kim JT, Marmor MF, Yoon YH.
    Ophthalmology; 2015 Jun 04; 122(6):1252-6. PubMed ID: 25712474
    [Abstract] [Full Text] [Related]

  • 13. Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence.
    Osmani Z, Schrama TJ, Zacouris-Verweij W, Andersen J, Frankel S, Bultink IEM, Cornet A, van Vollenhoven RF.
    Lupus Sci Med; 2021 Mar 04; 8(1):. PubMed ID: 33795484
    [Abstract] [Full Text] [Related]

  • 14. Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases.
    Eo DR, Lee MG, Ham DI, Kang SW, Lee J, Cha HS, Koh E, Kim SJ.
    J Korean Med Sci; 2017 Mar 04; 32(3):522-527. PubMed ID: 28145658
    [Abstract] [Full Text] [Related]

  • 15. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
    Tsang AC, Ahmadi Pirshahid S, Virgili G, Gottlieb CC, Hamilton J, Coupland SG.
    Ophthalmology; 2015 Jun 04; 122(6):1239-1251.e4. PubMed ID: 25824328
    [Abstract] [Full Text] [Related]

  • 16. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.
    Tanga L, Centofanti M, Oddone F, Parravano M, Parisi V, Ziccardi L, Kroegler B, Perricone R, Manni G.
    Graefes Arch Clin Exp Ophthalmol; 2011 May 04; 249(5):715-21. PubMed ID: 21253758
    [Abstract] [Full Text] [Related]

  • 17. [Update on recommendations for screening for hydroxychloroquine retinopathy].
    Couturier A, Giocanti-Aurégan A, Dupas B, Girmens JF, Le Mer Y, Massamba N, Barreau E, Audo I, DHU Vision, and Handicap task force rétine.
    J Fr Ophtalmol; 2017 Nov 04; 40(9):793-800. PubMed ID: 29054477
    [Abstract] [Full Text] [Related]

  • 18. Hydrochloroquine retinopathy: characteristic presentation with review of screening.
    Stelton CR, Connors DB, Walia SS, Walia HS.
    Clin Rheumatol; 2013 Jun 04; 32(6):895-8. PubMed ID: 23515601
    [Abstract] [Full Text] [Related]

  • 19. Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity.
    Martínez-Costa L, Victoria Ibañez M, Murcia-Bello C, Epifanio I, Verdejo-Gimeno C, Beltrán-Catalán E, Marco-Ventura P.
    Can J Ophthalmol; 2013 Oct 04; 48(5):400-5. PubMed ID: 24093187
    [Abstract] [Full Text] [Related]

  • 20. Risk of Retinal Toxicity in Longterm Users of Hydroxychloroquine.
    Kim JW, Kim YY, Lee H, Park SH, Kim SK, Choe JY.
    J Rheumatol; 2017 Nov 04; 44(11):1674-1679. PubMed ID: 28864645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.